Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 10, 2022Journal of Korean Medical AssociationOpen Access

Cardiac devices including CRT and ICDs remain essential for optimal heart failure management.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The rapidly increasing incidence of heart failure introduces a significant clinical burden, highlighting the need to review non-pharmacological cardiac device therapy as an essential component of optimal management.

Design

Review

Key result

Cardiac device therapies, including cardiac resynchronization therapy and implantable cardioverter-defibrillators, have been established as essential components for optimal heart failure management.

Authors

SPSeung‐Jung ParkInterventional Cardiology

Discussion

Loading...

Member takes

Overview

Emerging conduction system pacing may enhance CRT response in HF; leaves open superiority over biventricular pacing in randomized trials.

Structured PICO

P
Population
A review article summarizing the current concepts, efficacy, and safety of non-pharmacological cardiac device therapies, including CRT, ICD, and CCM, for the management of heart failure.
I
Intervention
Cardiac device therapy including cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillators (ICDs), and cardiac contractility modulation therapy

Recent advancements in cardiac device therapy, such as conduction system pacing and cardiac contractility modulation, offer improved management options for heart failure patients.

Limitations

  • Evidence for new conduction system pacing CRT methods is mostly limited to small, short-term retrospective studies.
  • The benefit of primary prevention ICDs in non-ischemic heart failure is less clear in the era of modern optimal medical therapy.

Cite This Study

Seung‐Jung Park (2022) conducted a review in Heart failure. Cardiac device therapy (CRT, ICD, CCM) was evaluated. Cardiac device therapies, including cardiac resynchronization therapy and implantable cardioverter-defibrillators, have been established as essential components for optimal heart failure management.

synapsesocial.com/papers/6aa148b5dc6fbdec443d48c7https://doi.org/10.5124/jkma.2022.65.1.26
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Device based treatment of heart failure2005 · 6 citations
  2. 2Device Therapies: New Indications and Future Directions2014 · 10 citations
  3. 3Cardiac Resynchronization Therapy:. Device-Based Medicine for Heart Failure2004 · 16 citations
  4. 4Role and Indications for Device Therapies in Heart Failure: Condensed Summary2025
  5. 5Electrical therapies in heart failure: Evolving technologies and indications2023 · 1 citations